You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 28, 2025

Drug Price Trends for GNP SENNA PLUS


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for GNP SENNA PLUS

Average Pharmacy Cost for GNP SENNA PLUS

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
GNP SENNA PLUS 8.6-50 MG TAB 46122-0625-72 0.03085 EACH 2025-04-23
GNP SENNA PLUS 8.6-50 MG TAB 46122-0625-72 0.03041 EACH 2025-03-19
GNP SENNA PLUS 8.6-50 MG TAB 46122-0625-72 0.02887 EACH 2025-02-19
GNP SENNA PLUS 8.6-50 MG TAB 46122-0625-72 0.02860 EACH 2025-01-22
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for GNP SENNA PLUS

Market Overview

GNP SENNA PLUS, a combination of docusate and senna, is a widely used laxative for treating constipation. Here’s a detailed analysis of the market and price projections for this medication.

Global Sennosides Market

The global sennosides market, which includes products like GNP SENNA PLUS, is expected to grow significantly. By 2023, the global sennosides market is valued at approximately $359.5 million and is projected to reach $548.5 million by 2033, growing at a CAGR of 4.3% during this period[1].

Market Drivers

Several factors drive the demand for sennosides and related products like GNP SENNA PLUS:

  • Increasing Prevalence of Constipation: Constipation is a common clinical ailment affecting a significant portion of the population. The rising cases of constipation globally are a key driver for the sales of sennosides[1].
  • Health Awareness: Growing health awareness among people and the preference for natural extracts in treating constipation also boost the demand for sennosides.
  • Pre-Colonoscopy Use: The use of sennosides to clean the intestine before a colonoscopy further increases their demand[1].

Price Analysis

Current Pricing

The cost of GNP SENNA PLUS, which is a combination of docusate and senna, varies based on the quantity and pharmacy.

  • For a supply of 100 tablets of docusate/senna (50 mg-8.6 mg), the cost is around $10.82 to $11, depending on the pharmacy[2][4].
  • For a smaller supply of 30 tablets of Senna Plus (50 mg-8.6 mg), the cost is approximately $9.90 to $10[4].

Price Trends

The prices of sennosides and related products have been relatively stable, with minor fluctuations due to factors like stock shortages and pharmacy variations.

  • Discount Programs: The use of discount cards, such as those offered by Drugs.com, can significantly reduce the cost of these medications, saving up to 80% or more[2][4].

Regional Market Analysis

The market for sennosides is analyzed across various regions:

  • North America: This region is a significant market for sennosides, with the USA and Canada being key countries. The market here is driven by high health awareness and the prevalence of constipation[1].
  • Latin America: Countries in Latin America also contribute to the growing demand for sennosides due to increasing health care needs and awareness[1].
  • Europe: Western and Eastern Europe are other key regions, with a substantial market share. The demand here is driven by both acute and chronic constipation cases[1].
  • Middle East and Africa: These regions are also seeing a rise in demand due to growing health care infrastructure and awareness about constipation treatments[1].

Market Attractiveness

The attractiveness of the sennosides market, including GNP SENNA PLUS, can be analyzed based on several factors:

  • Drug Type: Sennosides lead the market with a share of around 71.7% due to their easy availability and low cost[1].
  • Dosage Type: The demand for oral tablets is high, given their convenience and effectiveness.
  • Application: The use of sennosides for treating constipation and preparing for colonoscopies makes them highly attractive[1].
  • Distribution Channel: Pharmacies and online retailers are key distribution channels, with discounts and coupons often available to reduce costs[2][4].

Key Takeaways

  • Growing Demand: The global sennosides market is expected to grow at a CAGR of 4.3% from 2023 to 2033.
  • Price Stability: Prices for GNP SENNA PLUS are relatively stable, with discounts available through various programs.
  • Regional Growth: North America, Latin America, Europe, and the Middle East & Africa are significant regions driving the market.
  • Health Awareness: Increasing health awareness and the prevalence of constipation are key drivers for the market.

FAQs

1. What is the projected market value of the global sennosides market by 2033?

The global sennosides market is projected to reach $548.5 million by 2033[1].

2. What is the current cost of GNP SENNA PLUS for a supply of 100 tablets?

The current cost for a supply of 100 tablets of docusate/senna (50 mg-8.6 mg) is around $10.82 to $11[2][4].

3. What are the main drivers for the demand of sennosides?

The main drivers include the increasing prevalence of constipation, growing health awareness, and the use of sennosides for pre-colonoscopy preparation[1].

4. Are there any discount programs available for GNP SENNA PLUS?

Yes, discount cards like those from Drugs.com can save up to 80% or more on the cost of these medications[2][4].

5. Which regions are key markets for sennosides?

Key regions include North America, Latin America, Europe, and the Middle East & Africa[1].

Cited Sources

  1. Future Market Insights: Sennosides Market Size, Share, Trend & Outlook by 2033.
  2. Drugs.com: Docusate/senna Prices, Coupons, Copay Cards & Patient Assistance.
  3. DrugPatentWatch: Pharmaceutical drug prices and trends for GNP SENNA LAX.
  4. Drugs.com: Senna Plus Prices, Coupons, Copay Cards & Patient Assistance.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.